These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26692443)

  • 1. Increased Expression of the Glucose Transporter Type 1 Gene Is Associated With Worse Overall Survival in Resected Pancreatic Adenocarcinoma.
    Davis-Yadley AH; Abbott AM; Pimiento JM; Chen DT; Malafa MP
    Pancreas; 2016 Aug; 45(7):974-9. PubMed ID: 26692443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative High Maximum Standardized Uptake Value in Association with Glucose Transporter 1 Predicts Poor Prognosis in Pancreatic Cancer.
    Chikamoto A; Inoue R; Komohara Y; Sakamaki K; Hashimoto D; Shiraishi S; Takamori H; Yamashita YI; Yoshida N; Yamanaka T; Yamashita Y; Baba H
    Ann Surg Oncol; 2017 Jul; 24(7):2040-2046. PubMed ID: 28180987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing prognostic factors of Glut-1 expression and maximum standardized uptake value by FDG-PET in patients with resectable pancreatic cancer.
    Takahashi M; Nojima H; Kuboki S; Horikoshi T; Yokota T; Yoshitomi H; Furukawa K; Takayashiki T; Takano S; Ohtsuka M
    Pancreatology; 2020 Sep; 20(6):1205-1212. PubMed ID: 32819845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of dual-point fluorine-18 fluorodeoxyglucose PET imaging, partial volume correction and glucose transporter-1 expression in resected nonsmall cell lung cancer patients.
    Kaida H; Azuma K; Kawahara A; Takamori S; Akiba J; Fujimoto K; Ishii K; Ishibashi M
    Nucl Med Commun; 2020 Jan; 41(1):48-57. PubMed ID: 31764590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in gastric carcinoma: relation to histological subtypes, depth of tumor invasion, and glucose transporter-1 expression.
    Yamada A; Oguchi K; Fukushima M; Imai Y; Kadoya M
    Ann Nucl Med; 2006 Nov; 20(9):597-604. PubMed ID: 17294670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Significance of
    Zheng H; Cui Y; Li X; Du B; Li Y
    Clin Lung Cancer; 2019 Nov; 20(6):420-428. PubMed ID: 31300363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between [18F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1α and glucose transporter 1 in non-small cell lung cancer.
    Furukawa T; Miyata Y; Kushitani K; Mimae T; Tsutani Y; Takeshima Y; Okada M
    Jpn J Clin Oncol; 2015 Dec; 45(12):1154-61. PubMed ID: 26386467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDG uptake, GLUT-1 glucose transporter and cellularity in human pancreatic tumors.
    Higashi T; Tamaki N; Torizuka T; Nakamoto Y; Sakahara H; Kimura T; Honda T; Inokuma T; Katsushima S; Ohshio G; Imamura M; Konishi J
    J Nucl Med; 1998 Oct; 39(10):1727-35. PubMed ID: 9776278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDG uptake, glucose transporter type 1, and Ki-67 expressions in non-small-cell lung cancer: correlations and prognostic values.
    Nguyen XC; Lee WW; Chung JH; Park SY; Sung SW; Kim YK; So Y; Lee DS; Chung JK; Lee MC; Kim SE
    Eur J Radiol; 2007 May; 62(2):214-9. PubMed ID: 17239556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose transporter-1 expression and prognostic significance in pancreatic carcinogenesis.
    Pizzi S; Porzionato A; Pasquali C; Guidolin D; Sperti C; Fogar P; Macchi V; De Caro R; Pedrazzoli S; Parenti A
    Histol Histopathol; 2009 Feb; 24(2):175-85. PubMed ID: 19085834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of SUVmax and GLUT-1 Expression in Determining Tumor Aggressiveness in Patients With Clinical Stage I Endometrioid Endometrial Cancer.
    Lee DW; Chong GO; Lee YH; Hong DG; Cho YL; Jeong SY; Park JY; Lee YS
    Int J Gynecol Cancer; 2015 Jun; 25(5):843-9. PubMed ID: 25347093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of precursor lesions of pancreatic adenocarcinoma in PET-CT in a genetically engineered mouse model of pancreatic cancer.
    Fendrich V; Schneider R; Maitra A; Jacobsen ID; Opfermann T; Bartsch DK
    Neoplasia; 2011 Feb; 13(2):180-6. PubMed ID: 21403843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-D-glucose uptake by positron emission tomography in colorectal cancer.
    Gu J; Yamamoto H; Fukunaga H; Danno K; Takemasa I; Ikeda M; Tatsumi M; Sekimoto M; Hatazawa J; Nishimura T; Monden M
    Dig Dis Sci; 2006 Dec; 51(12):2198-205. PubMed ID: 17080242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Expression and Survival Significance of Glucose Transporter-1 in Pancreatic Cancer: Meta-Analysis, Bioinformatics Analysis and Retrospective Study.
    Du J; Gu J; Deng J; Kong L; Guo Y; Jin C; Bao Y; Fu D; Li J
    Cancer Invest; 2021 Oct; 39(9):741-755. PubMed ID: 34229540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
    Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
    Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-Fluorodeoxyglucose Positron Emission Tomography Predicts Treatment Efficacy and Clinical Outcome for Patients With Pancreatic Carcinoma: A Meta-analysis.
    Wang L; Dong P; Shen G; Hou S; Zhang Y; Liu X; Tian B
    Pancreas; 2019 Sep; 48(8):996-1002. PubMed ID: 31404025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between 18F-fluorodeoxyglucose positron emission tomography and pathologic differentiation in pancreatic cancer.
    Ahn SJ; Park MS; Lee JD; Kang WJ
    Ann Nucl Med; 2014 Jun; 28(5):430-5. PubMed ID: 24623151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma.
    Reske SN; Grillenberger KG; Glatting G; Port M; Hildebrandt M; Gansauge F; Beger HG
    J Nucl Med; 1997 Sep; 38(9):1344-8. PubMed ID: 9293784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological subtypes of lung adenocarcinoma have differential ¹⁸F-fluorodeoxyglucose uptakes on the positron emission tomography/computed tomography scan.
    Chiu CH; Yeh YC; Lin KH; Wu YC; Lee YC; Chou TY; Tsai CM
    J Thorac Oncol; 2011 Oct; 6(10):1697-703. PubMed ID: 21869716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative FDG-PET predicts early recurrence and a poor prognosis after resection of pancreatic adenocarcinoma.
    Yamamoto T; Sugiura T; Mizuno T; Okamura Y; Aramaki T; Endo M; Uesaka K
    Ann Surg Oncol; 2015 Feb; 22(2):677-84. PubMed ID: 25190125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.